ncRNA name
hsa-miR-223
Specific or universal ncRNAs
Universal ncRNAs
Class
MicroRNA
Biomarker
Yes
Biomarker application
Treatment
Upstream regulatory factors
Not available
Downstream target
ABCB1
Cancer name
Hepatocellular Carcinoma
Cancer site
Liver
Treatment type
Chemotherapy
Drug
Cisplatin/5-Fluorouracil
Impact of wild-type ncRNA on chemotherapy resistance
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
Down
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
The over-expression of miR-223 increased the HCC cell sensitivity to anticancer drugs, and the inhibition of miR-223 had the opposite effect.
Tissue resource
hepatocellular carcinoma cell lines BEL-7402
hepatocellular carcinoma cell lines Hep3B
hepatocellular carcinoma cell lines HepG2
hepatocellular carcinoma cell lines HCC3
hepatocellular carcinoma cell lines Huh-7
hepatocellular carcinoma cell lines LM-6
hepatocellular carcinoma cell lines SMMC7721
hepatocellular carcinoma cell lines SK-Hep-1
Experiment
qRT-PCR,Western blot
Institute
Country
Continent